UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 981

Sortiert nach

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

Clinical cancer research, 2017-07, Vol.23 (14), p.3711-3720

2017

Volltextzugriff (PDF)

The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis

Journal of biomedical science, 2020-07, Vol.27 (1), p.77-77, Article 77

2020

Volltextzugriff (PDF)

TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

The Journal of clinical investigation, 2021-04, Vol.131 (8), p.1-13

2021

Volltextzugriff (PDF)

Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1

Genome medicine, 2020-09, Vol.12 (1), p.83-83, Article 83

2020

Volltextzugriff (PDF)

Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy

Cancer cell, 2019-08, Vol.36 (2), p.168-178.e4

2019

Volltextzugriff (PDF)

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

Molecular cell, 2018-08, Vol.71 (4), p.606-620.e7

2018

Volltextzugriff (PDF)

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1

Cancer cell, 2018-02, Vol.33 (2), p.187-201.e10

2018

Volltextzugriff (PDF)

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

Nature communications, 2016-08, Vol.7 (1), p.12632-11, Article 12632

2016

Volltextzugriff (PDF)

TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma

Molecular cancer, 2022-09, Vol.21 (1), p.1-185, Article 185

2022

Volltextzugriff (PDF)

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion

The Journal of clinical investigation, 2019-08, Vol.129 (8), p.3324-3338

2019

Volltextzugriff (PDF)

Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity

Cancer research (Chicago, Ill.), 2020-06, Vol.80 (11), p.2298-2310

2020

Volltextzugriff (PDF)

EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (5), p.1284-1296

2016

Volltextzugriff (PDF)

Fluorescent water‐stable Zn (II) coordination polymers for selective aqueous detection of nitrophenols

Applied organometallic chemistry, 2023-04, Vol.37 (4), p.n/a

2023

Volltextzugriff (PDF)

Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma

The Journal of clinical investigation, 2023-02, Vol.133 (3), p.1-14

2023

Volltextzugriff (PDF)

Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma

Haematologica (Roma), 2023-05, Vol.108 (5), p.1412

2023

Volltextzugriff (PDF)

Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma

Nature communications, 2024-02, Vol.15 (1), p.1009-1009, Article 1009

2024

Volltextzugriff (PDF)

A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases

Journal of biomedical science, 2018-11, Vol.25 (1), p.83-83, Article 83

2018

Volltextzugriff (PDF)

Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma

Oncotarget, 2021-09, Vol.12 (20), p.2089-2100

2021

Volltextzugriff (PDF)

p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs

Nature cell biology, 2011-03, Vol.13 (3), p.317

2011

Volltextzugriff (PDF)

Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology

Molecular aspects of medicine, 2019-12, Vol.70, p.106-116

2019

Volltextzugriff (PDF)

Juxtacrine Signaling Inhibits Antitumor Immunity by Upregulating PD-L1 Expression

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (14), p.3761-3768

2018

Volltextzugriff (PDF)

Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer

Cancer cell, 2018-04, Vol.33 (4), p.752-769.e8

2018

Volltextzugriff (PDF)

Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation

International journal of biological sciences, 2023-01, Vol.19 (10), p.2957-2973

2023

Volltextzugriff (PDF)

Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial

Future oncology (London, England), 2018-03, Vol.14 (6), p.515-525

2018

Volltextzugriff (PDF)

Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins

Cell death & disease, 2023-11, Vol.14 (11), p.714-714, Article 714

2023

Volltextzugriff (PDF)

1 – 25 von 981

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(812)
Mit Volltextzugriff
(904)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(656)
Life Sciences & Biomedicine
(374)
Humans
(198)
Technology
(175)
Physical Sciences
(174)
Animals
(127)
Chemistry
(98)
Male
(97)
Female
(95)
Mice
(78)
Engineering
(77)
Materials Science
(67)
Science & Technology - Other Topics
(66)
Physics
(58)
Biochemistry & Molecular Biology
(51)
Materials Science, Multidisciplinary
(49)
Adult
(48)
Cell Biology
(47)
Oncology
(46)
Middle Aged
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(20)
... seit 30 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis

TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1

Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion

Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity

EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape

Fluorescent water‐stable Zn (II) coordination polymers for selective aqueous detection of nitrophenols

Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma

Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma

Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma

A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases

Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma

p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs

Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology

Juxtacrine Signaling Inhibits Antitumor Immunity by Upregulating PD-L1 Expression

Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer

Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation

Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial

Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins

Suchergebnisse filtern